ArticleCancer research communications2023

The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.

Giulia Dellavedova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.